Johnson & Johnson - Payout Ratio History
Payout ratio history for stock JNJ (Johnson & Johnson).
Date | Payout ratio |
---|---|
September 2023 | 42.05% |
August 2023 | 43.00% |
July 2023 | 43.27% |
June 2023 | 41.09% |
May 2023 | 41.51% |
April 2023 | 41.87% |
March 2023 | 41.76% |
February 2023 | 41.43% |
January 2023 | 43.42% |
December 2022 | 43.46% |
November 2022 | 43.38% |
October 2022 | 42.68% |
September 2022 | 43.46% |
August 2022 | 43.55% |
July 2022 | 43.38% |
June 2022 | 43.38% |
May 2022 | 40.69% |
April 2022 | 40.69% |
March 2022 | 40.69% |
February 2022 | 40.69% |
January 2022 | 40.69% |
December 2021 | 40.69% |
October 2021 | 63.76% |
September 2021 | 63.76% |
August 2021 | 74.91% |
July 2021 | 74.91% |
June 2021 | 74.91% |
May 2021 | 73.32% |
April 2021 | 73.32% |
March 2021 | 73.32% |
February 2021 | 63.52% |
January 2021 | 63.52% |
December 2020 | 59.75% |
November 2020 | 58.90% |
October 2020 | 65.90% |
September 2020 | 65.90% |
August 2020 | 65.90% |
July 2020 | 58.43% |
June 2020 | 58.43% |
May 2020 | 67.74% |
April 2020 | 67.74% |
March 2020 | 67.74% |
February 2020 | 67.74% |
January 2020 | 67.74% |
December 2019 | 67.74% |
November 2019 | 67.74% |
October 2019 | 67.74% |
September 2019 | 67.74% |
August 2019 | 67.74% |
July 2019 | 67.74% |
June 2019 | 67.74% |
May 2019 | 67.74% |
April 2019 | 64.17% |
March 2019 | 64.17% |
February 2019 | 64.17% |
December 2018 | 589.80% |
December 2017 | 57% |
December 2016 | 54.40% |
December 2015 | 55.60% |
December 2014 | 45% |
December 2013 | 56.70% |
December 2012 | 62.10% |
December 2011 | 54.10% |
December 2010 | 44.10% |
December 2009 | 43.80% |
December 2008 | 43.05% |
December 2007 | 43.24% |
December 2006 | 43.14% |
December 2005 | 42.31% |
December 2004 | 42.18% |
December 2003 | 43.93% |
December 2002 | 41.84% |
December 2001 | 41.34% |
December 2000 | 41.73% |
December 1999 | 42.27% |
JNJ
List: Champions
Price: 157.11USD
Dividend Yield: 2.97%
Forward Dividend Yield: 2.99%
Payout Ratio: 42.05%
Dividend Per Share: 4.76 USD
Earnings Per Share: 10.90 USD
P/E Ratio: 32.23
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers—General
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 384.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 62
DGR3: 5.62%
DGR5: 5.76%
DGR10: 5.98%
DGR20: 8.22%